财中社1月13日电药师帮(09885)发布公告,董事会宣布于2025年1月13日根据股份激励计划购回10万股股份,总代价为55万港元,平均价格约为每股5.48港元。此次回购是为满足根据股份激励计划授出的奖励,受托人将以信托方式持有和管理相关资金及财产。
董事会认为,当前股价低于内在价值,未能充分反映公司的业务前景,回购股份为补充信托基金提供了良好机会。同时,此举也展示了公司对未来发展的信心,旨在吸引人才并推动关键员工利益与公司利益的一致性,促进集团的可持续增长。公司作为中国院外医药产业最大的数字化综合服务平台,致力于通过高效的互联网医药流通网络和医疗科技创新,推动产业健康发展。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.